
News|Articles|June 8, 2026
5 Essential Capabilities for Decentralized Clinical Trials
Author(s)Quest Diagnostics
Key Takeaways
- Decentralized clinical trials are positioned as a foundational competency as clinical research continues shifting toward broader access and real-world evidence generation.
- Expanded participation is enabled by reducing geographic and logistical barriers for patients, supporting more inclusive enrollment and retention.
Advertisement
As the clinical research landscape evolves, decentralized clinical trials (DCTs) have emerged as a foundational competency, enabling broader patient participation, increasing trial efficiency, and driving more inclusive, real-world data collection. However, the successful execution of DCTs requires more than just innovative technology—it demands a comprehensive strategy that addresses the unique challenges of decentralization.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Beyond Revenue Recognition: Rethinking CRO Contracting Through the CURED Shared Performance Contract
2
Two Decades of Rising Protocol Complexity: A Longitudinal Analysis of Clinical Trial Design Evolution, 2004–2025
3
HHS Launches Operation TrialBlazer to Restore US Leadership in Clinical Research
4
Nature Medicine Retracts Viral Lung Cancer Timing Study After Four-Month Investigation
5




